Prevention of Diabetic Complications by Activation of Nrf2: Diabetic Cardiomyopathy and Nephropathy

被引:114
|
作者
Li, Bing [1 ,2 ,3 ]
Liu, Shujun [2 ]
Miao, Lining [1 ]
Cai, Lu [3 ]
机构
[1] Jilin Univ, Dept Nephrol, Hosp 2, Changchun 130042, Peoples R China
[2] Jilin Prov Peoples Hosp, Dept Nephrol, Changchun 130041, Peoples R China
[3] Univ Louisville, KCHRI Pediat Diabet Res Labs, Dept Pediat, Louisville, KY 40202 USA
关键词
OXIDATIVE STRESS; BARDOXOLONE METHYL; INSULIN-RESISTANCE; ENDOTHELIAL-CELLS; CDDO-IMIDAZOLIDE; KIDNEY-FUNCTION; HYPERGLYCEMIA; DYSFUNCTION; RESVERATROL; TRITERPENOIDS;
D O I
10.1155/2012/216512
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic cardiomyopathy and nephropathy are two major causes of death of patients with diabetes. Extra generation of reactive oxygen species (ROS), induced by hyperglycemia, is considered as the main reason for the development of these diabetic complications. Transcription factor, NFE2-related factor 2 (Nrf2), is a master regulator of cellular detoxification response and redox status, and also provides a protective action from various oxidative stresses and damages. Recently we have demonstrated its important role in determining the susceptibility of cells or tissues to diabetes-induced oxidative stress and/or damage. Therefore, this review will specifically summarize the information available regarding the effect of Nrf2 on the diabetic complications with a focus on diabetic cardiomyopathy and nephropathy. Given the feature that Nrf2 is easily induced by several compounds, we also discussed the role of different Nrf2 activators in the prevention or therapy of various diabetic complications. These findings suggest that Nrf2 has a potential application in the clinic setting for diabetic patients in the short future.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Prevention of Diabetic Nephropathy by Sulforaphane: Possible Role of Nrf2 Upregulation and Activation
    Cui, Wenpeng
    Bai, Yang
    Miao, Xiao
    Luo, Ping
    Chen, Qiang
    Tan, Yi
    Rane, Madhavi J.
    Miao, Lining
    Cai, Lu
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2012, 2012
  • [2] Prevention by Sulforaphane of Diabetic Cardiomyopathy is Associated With Nrf2 Up-Regulation and Activation
    Bai, Yang
    Zheng, Yang
    Chen, Qiang
    Miao, Xiao
    Zhang, Chi
    Cui, Wenpeng
    Tan, Yi
    Cai, Lu
    DIABETES, 2012, 61 : A120 - A120
  • [3] Diabetic Cardiomyopathy and Its Prevention by Nrf2: Current Status
    Chen, Jing
    Zhang, Zhiguo
    Cai, Lu
    DIABETES & METABOLISM JOURNAL, 2014, 38 (05) : 337 - 345
  • [4] Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation
    Bai, Yang
    Cui, Wenpeng
    Xin, Ying
    Miao, Xiao
    Barati, Michelle T.
    Zhang, Chi
    Chen, Qiang
    Tan, Yi
    Cui, Taixing
    Zheng, Yang
    Cai, Lu
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2013, 57 : 82 - 95
  • [5] Metallothionein Is Downstream of Nrf2 and Partially Mediates Sulforaphane Prevention of Diabetic Cardiomyopathy
    Gu, Junlian
    Cheng, Yanli
    Wu, Hao
    Kong, Lili
    Wang, Shudong
    Xu, Zheng
    Zhang, Zhiguo
    Tan, Yi
    Keller, Bradley B.
    Zhou, Honglan
    Wang, Yuehui
    Xu, Zhonggao
    Cai, Lu
    DIABETES, 2017, 66 (02) : 529 - 542
  • [6] Role of Nrf2 gene polymorphism in diabetic nephropathy
    Jia, Yueyue
    Wang, Xiaoxia
    Zhang, Xiyao
    Zhang, Sijia
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34
  • [7] Nrf2 Activators as Attractive Therapeutics or Diabetic Nephropathy
    de Haan, Judy B.
    DIABETES, 2011, 60 (11) : 2683 - 2684
  • [8] Nrf2 signaling in diabetic nephropathy, cardiomyopathy and neuropathy: Therapeutic targeting, challenges and future prospective
    Hashemi, Mehrdad
    Zandieh, Mohammad Arad
    Ziaolhagh, Setayesh
    Mojtabavi, Sarah
    Sadi, Farzaneh Hasani
    Koohpar, Zeinab Khazaei
    Ghanbarirad, Maryam
    Haghighatfard, Arvin
    Behroozaghdam, Mitra
    Khorrami, Ramin
    Nabavi, Noushin
    Ren, Jun
    Reiter, Russel J.
    Salimimoghadam, Shokooh
    Rashidi, Mohsen
    Hushmandi, Kiavash
    Taheriazam, Afshin
    Entezari, Maliheh
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2023, 1869 (05):
  • [9] Cardioprotective effects of asiaticoside against diabetic cardiomyopathy: Activation of the AMPK/Nrf2 pathway
    Xu, Chennian
    Xia, Lin
    Xu, Dengyue
    Liu, Yang
    Jin, Ping
    Zhai, Mengen
    Mao, Yu
    Wang, Yiwei
    Wen, Anguo
    Yang, Jian
    Yang, Lifang
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (02)
  • [10] Fenofibrate Prevented Diabetic Nephropathy by Upregulating FGF21-mediated Nrf2 Activation
    Cheng, Yanli
    Xu, Zhonggao
    Cai, Lu
    DIABETES, 2015, 64 : A146 - A146